All You Need to Know About Aptevo Therapeutics Inc. (APVO) Rating Upgrade to BuyZacks Investment Research • 06/30/20
Has Aptevo Therapeutics (APVO) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 06/30/20
Aptevo Therapeutics and Alligator Bioscience Present new Preclinical Data for ALG.APV-527 at the PEGS Virtual Interactive Global SummitPRNewsWire • 06/10/20
Aptevo Therapeutics Receives Orphan Drug Designation for APVO436 for the Treatment of Acute Myelogenous LeukemiaGlobeNewsWire • 12/06/19
Aptevo Therapeutics Introduces New Adaptir™ Bispecific Antibody Candidate Intended for the Treatment of Solid TumorsGlobeNewsWire • 09/19/19